CID is 36294
synonyms found at PubChem are:
tobramycin, 32986-56-4, Nebramycin 6, Nebramycin VI, Tobramicin, Tobramycetin, Nebcin, 3'-Deoxykanamycin B, Aktob, Tobi, NEBRAMYCIN, Nebramycin factor 6, Tobramycinum, Tobralex, Tobramicina, Tobramycine, 1-Epitobramycin, Deoxykanamycin B, Tobracin, Gotabiotic, Nebicin, Tobacin, Tobrased, Tobramycin Base, Tobi Podhaler, Tenebrimycin, Tobradistin, Tobramaxin, Tobramitsetin, Tenemycin, Tobrex, TOBRAMYCIN SULFATE, Obramycin, Tobradex, UNII-VZ8RRZ51VK, Tobramycine [INN-French], Tobramycinum [INN-Latin], Tobramicina [INN-Spanish], Brulamycin, Tobracin (TN), Tobrasone, Nebramycin factir 6, HSDB 3259, C18H37N5O9, Lilly 47663, EINECS 251-322-5, VZ8RRZ51VK, SPRC-AB01, NSC 180514, BRN 1357507, Distobram, NF 6, CHEBI:28864, tobramycin solution for inhalation, NLVFBUXFDBBNBW-PBSUHMDJSA-N, Tobrex (TN), D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-, 4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine, Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-tyrideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-, Sybryx, vantobra, Bethkis, Nebcin (Sulfate), Kitabis Pak, Gernebcin, (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol, (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6))-2-deoxy-L-streptamine, Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-, TOY, Tobramycin for Inhalation, SR-05000001726, torbamycin, TOA-(1-6)TOB-(4-1)TOC, Tobramycin,(S), Tobramycin [USAN:BAN:INN:JAN], NCGC00016814-01, TOA-(1-6)2TB-(4-1)TOC, (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside, (2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol, Bethkis (TN), CAS-32986-56-4, Nebramycin-Faktor 6, Tobramycin [2M+H], Tobramycin [USAN:USP:INN:BAN:JAN], Tobi (TN), Spectrum_001072, AC1Q2AOW, Prestwick3_000544, Spectrum2_000078, Spectrum3_000588, Spectrum4_000752, Spectrum5_001038, DSSTox_CID_3680, ro-2H-pyran-3,5-diol, Tobramycin (JP17/USP), AC1L1VI0, SCHEMBL2838, CHEMBL1747, DSSTox_RID_77144, DSSTox_GSID_23680, BSPBio_000587, BSPBio_002036, KBioGR_001104, KBioSS_001552, MLS000069544, BIDD:GT0503, SPECTRUM1500579, SPBio_000295, BPBio1_000647, DTXSID8023680, KBio2_001552, KBio2_004120, KBio2_006688, KBio3_001536, AOB5629, BIT0802, MolPort-003-665-548, ZX-AFC000193, 49842-07-1 (Sulfate), HMS2090B16, HMS2092M17, HMS2096N09, HMS3713N09, Pharmakon1600-01500579, HY-B0441, ZINC8214692, Tox21_110626, BDBM50366778, CCG-39936, MFCD00077885, NSC757352, s2514, AKOS016339662, AN-9578, API0004434, CS-2547, DB00684, KS-1405, NSC-757352, NCGC00178852-01, NCGC00178852-02, CC-35084, CPD000058793, SAM001246911, SC-45657, SMR000058793, SBI-0051915.P003, AB2000616, LS-146940, LS-187329, AB00513858, A-8891, C00397, D00063, J10405, AB00052438-12, AB00052438_13, AB00052438_14, 986T564, C-22669, SR-01000721898, Tobramycin, Antibiotic for Culture Media Use Only, Q-201837, SR-01000721898-2, SR-05000001726-1, SR-05000001726-2, BRD-K05619559-001-12-7, UNII-NQJ13I4Z9U component NLVFBUXFDBBNBW-PBSUHMDJSA-N, (1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside, (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahyd, (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol, (2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol, 11098-01-4, 11111-45-8, 34337-51-4, 37321-13-4, 4-AMINO-2-[4,6-DIAMINO-3-(3-AMINO-6-AMINOMETHYL-5-HYDROXY-TETRAHYDRO-PYRAN-2-YLOXY)-2-HYDROXY-CYCLOHEXYLOXY]-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL, 54330-95-9, 70322-33-7, D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribohexopyranosyl-(1->4)]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4))-2-deoxy-, O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-->4)]-2-deoxy-D-streptamine, O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-D-streptamine, O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-?-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine, O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-a -D-ribo-hexopyranosyl-(1-4)]-2-deoxy-D-streptamine, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine